News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,940 Results
Type
Article (5027)
Company Profile (17)
Press Release (219896)
Section
Business (82226)
Career Advice (461)
Deals (15045)
Drug Delivery (8)
Drug Development (19109)
Employer Resources (30)
FDA (3680)
Job Trends (3910)
News (120183)
Policy (7508)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (295)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14774)
ALS (19)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (11)
Approvals (3694)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2872)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (425)
Cardiovascular disease (21)
Career advice (391)
Career pathing (2)
CAR-T (30)
Cell therapy (101)
Cervical cancer (2)
Clinical research (16030)
Collaboration (163)
Compensation (151)
Complete response letters (2)
COVID-19 (311)
CRISPR (7)
C-suite (91)
Cystic fibrosis (16)
Data (492)
Depression (5)
Diabetes (38)
Diagnostics (2037)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40723)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37681)
Executive appointments (284)
FDA (3915)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (175)
Gene editing (15)
Generative AI (2)
Gene therapy (46)
GLP-1 (105)
Government (409)
Guidances (16)
Healthcare (5037)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (327)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7817)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (4)
Legal (2332)
Liver cancer (17)
Lung cancer (50)
Lymphoma (27)
Management (10)
Manufacturing (45)
MASH (27)
Medical device (3856)
Medtech (3857)
Mergers & acquisitions (7418)
Metabolic disorders (114)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (334)
NextGen: Class of 2025 (1674)
Non-profit (729)
Northern California (872)
Now hiring (2)
Obesity (51)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (4)
Patents (22)
Patient recruitment (27)
Peanut (5)
People (24531)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4780)
Phase II (6963)
Phase III (5546)
Pipeline (524)
Policy (4)
Postmarket research (627)
Preclinical (1870)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (64)
Real estate (1874)
Recruiting (8)
Regulatory (5107)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
RSV (1)
Schizophrenia (21)
Series A (26)
Series B (21)
Sickle cell disease (7)
Southern California (672)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
United States (6700)
Vaccines (37)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (29)
Last 7 days (248)
Last 30 days (890)
Last 365 days (10268)
2025 (2548)
2024 (11058)
2023 (13214)
2022 (18701)
2021 (19693)
2020 (18246)
2019 (13213)
2018 (10208)
2017 (10010)
2016 (9163)
2015 (12131)
2014 (9593)
2013 (7718)
2012 (8334)
2011 (8806)
2010 (8637)
Location
Africa (188)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11444)
Australia (1621)
California (1830)
Canada (667)
China (67)
Colorado (78)
Connecticut (90)
Delaware (28)
Europe (24550)
Florida (257)
Georgia (32)
Idaho (23)
Illinois (111)
India (6)
Indiana (59)
Iowa (1)
Japan (64)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (39)
Maryland (214)
Massachusetts (1477)
Michigan (84)
Minnesota (134)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (537)
New Mexico (5)
New York (454)
North Carolina (315)
North Dakota (2)
Northern California (872)
Ohio (54)
Oklahoma (5)
Oregon (3)
Pennsylvania (332)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (672)
Tennessee (35)
Texas (215)
Utah (57)
Virginia (41)
Washington D.C. (8)
Washington State (161)
West Virginia (2)
Wisconsin (20)
224,940 Results for "immunis corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunis’ Treats its First Patients for Sarcopenic Obesity
March 4, 2025
·
3 min read
Press Releases
Immunis Closes $25 Million Series A-1 Financing Round
January 13, 2025
·
3 min read
Press Releases
Immunis Appoints Dr. Christina Weng to its Advisory Board
Immunis, Inc., a private biotechnology company developing regenerative secretomes for age and disease-related immune dysfunction, is delighted to welcome Dr. Christina Weng as its newest Advisory Board member.
June 28, 2024
·
3 min read
Business
Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia
Immunis, Inc., a clinical-stage biotech developing innovative secretome therapies to address age-related disease and immune dysfunction, obtained a significant strategic milestone in partnering with Toray, a Japanese drug company part of the Toray Group.
May 22, 2024
·
3 min read
Biotech Beach
Immunis Publishes Research Showing Secretomes Improve Metabolism and Muscle While Reducing Fat in Aged Models
Immunis Inc. announces the peer-reviewed publication of research by Immunis and the University of Utah’s Professor Micah Drummond.
March 19, 2024
·
3 min read
Press Releases
Immunis Initiates Non-Terminal Preclinical Studies to Address Canine Muscle Atrophy
November 4, 2024
·
3 min read
Biotech Beach
Immunis Discusses with Experts Why the Immune System is the Key to Human Healthspan
Immunis Inc. is proud to unveil its latest video project entitled “Unlocking Lifelong Vitality: Immunis Aims to Supercharge Our Immune System for a Healthier Future.” This project features insights from world-renowned leaders in human health including Dr. Hans Keirstead, Jane Metcalfe, Dr. Peter Diamandis and Dr. Micah Drummond, who share a vision of revolutionizing human healthspan through the immune system.
April 5, 2024
·
3 min read
Press Releases
Immunis Successfully Completes its Phase 1/2a Clinical Trial Targeting Muscle Atrophy
November 19, 2024
·
3 min read
BioMidwest
Immunis.AI Announces Publication, in The Journal of Urology, of Results from Blood-Based Immune Profiling Study for Prostate Cancer Patients
IMMUNIS.AI, an immunogenomics company developing blood-based cancer surveillance technologies, today announced that results from a prostate cancer risk stratification study evaluating the company’s novel blood-based liquid biopsy platform were published in The Journal of Urology.
March 1, 2024
·
5 min read
Biotech Beach
Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot
Immunis, Inc., a private biotech company developing an innovative secretome for age-related diseases and immune dysfunction, announces that its Chairman, Dr. Hans Keirstead, will present at the annual Abundance360 in Los Angeles.
March 18, 2024
·
3 min read
1 of 22,494
Next